Industry Research Reports

Home > Reports > Pharma & Healthcare > Global TB Disease Vaccine Market Research Report 2025

Global TB Disease Vaccine Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-01

Pages: 91 Pages

Report ld: 3453155

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for TB Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn"t cause TB in healthy people but it helps develop some protection (immunity) against TB.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for TB Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Disease Vaccine.

The TB Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TB Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the TB Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC

Queen Saovabha Mem. Inst

Microgen

Segment by Type

Prevention Vaccines

Post-exposure Vaccines

Others

Segment by Application

Self-Procurement

UNICEF

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of TB Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of TB Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 TB Disease Vaccine Market Overview

1.1 Product Definition

1.2 TB Disease Vaccine by Type

1.2.1 Global TB Disease Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Prevention Vaccines

1.2.3 Post-exposure Vaccines

1.2.4 Others

1.3 TB Disease Vaccine by Application

1.3.1 Global TB Disease Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Self-Procurement

1.3.3 UNICEF

1.3.4 Others

1.4 Global TB Disease Vaccine Market Size Estimates and Forecasts

1.4.1 Global TB Disease Vaccine Revenue 2020-2031

1.4.2 Global TB Disease Vaccine Sales 2020-2031

1.4.3 Global TB Disease Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 TB Disease Vaccine Market Competition by Manufacturers

2.1 Global TB Disease Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global TB Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global TB Disease Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of TB Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of TB Disease Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of TB Disease Vaccine, Product Type & Application

2.7 Global Key Manufacturers of TB Disease Vaccine, Date of Enter into This Industry

2.8 Global TB Disease Vaccine Market Competitive Situation and Trends

2.8.1 Global TB Disease Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest TB Disease Vaccine Players Market Share by Revenue

2.8.3 Global TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global TB Disease Vaccine Market Scenario by Region

3.1 Global TB Disease Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global TB Disease Vaccine Sales by Region: 2020-2031

3.2.1 Global TB Disease Vaccine Sales by Region: 2020-2025

3.2.2 Global TB Disease Vaccine Sales by Region: 2026-2031

3.3 Global TB Disease Vaccine Revenue by Region: 2020-2031

3.3.1 Global TB Disease Vaccine Revenue by Region: 2020-2025

3.3.2 Global TB Disease Vaccine Revenue by Region: 2026-2031

3.4 North America TB Disease Vaccine Market Facts & Figures by Country

3.4.1 North America TB Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America TB Disease Vaccine Sales by Country (2020-2031)

3.4.3 North America TB Disease Vaccine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe TB Disease Vaccine Market Facts & Figures by Country

3.5.1 Europe TB Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe TB Disease Vaccine Sales by Country (2020-2031)

3.5.3 Europe TB Disease Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific TB Disease Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific TB Disease Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific TB Disease Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific TB Disease Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America TB Disease Vaccine Market Facts & Figures by Country

3.7.1 Latin America TB Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America TB Disease Vaccine Sales by Country (2020-2031)

3.7.3 Latin America TB Disease Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa TB Disease Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa TB Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa TB Disease Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa TB Disease Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global TB Disease Vaccine Sales by Type (2020-2031)

4.1.1 Global TB Disease Vaccine Sales by Type (2020-2025)

4.1.2 Global TB Disease Vaccine Sales by Type (2026-2031)

4.1.3 Global TB Disease Vaccine Sales Market Share by Type (2020-2031)

4.2 Global TB Disease Vaccine Revenue by Type (2020-2031)

4.2.1 Global TB Disease Vaccine Revenue by Type (2020-2025)

4.2.2 Global TB Disease Vaccine Revenue by Type (2026-2031)

4.2.3 Global TB Disease Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global TB Disease Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global TB Disease Vaccine Sales by Application (2020-2031)

5.1.1 Global TB Disease Vaccine Sales by Application (2020-2025)

5.1.2 Global TB Disease Vaccine Sales by Application (2026-2031)

5.1.3 Global TB Disease Vaccine Sales Market Share by Application (2020-2031)

5.2 Global TB Disease Vaccine Revenue by Application (2020-2031)

5.2.1 Global TB Disease Vaccine Revenue by Application (2020-2025)

5.2.2 Global TB Disease Vaccine Revenue by Application (2026-2031)

5.2.3 Global TB Disease Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global TB Disease Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck TB Disease Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Japan BCG Lab

6.2.1 Japan BCG Lab Company Information

6.2.2 Japan BCG Lab Description and Business Overview

6.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Japan BCG Lab TB Disease Vaccine Product Portfolio

6.2.5 Japan BCG Lab Recent Developments/Updates

6.3 Serum Institute of India

6.3.1 Serum Institute of India Company Information

6.3.2 Serum Institute of India Description and Business Overview

6.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Serum Institute of India TB Disease Vaccine Product Portfolio

6.3.5 Serum Institute of India Recent Developments/Updates

6.4 AJ Vaccines

6.4.1 AJ Vaccines Company Information

6.4.2 AJ Vaccines Description and Business Overview

6.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 AJ Vaccines TB Disease Vaccine Product Portfolio

6.4.5 AJ Vaccines Recent Developments/Updates

6.5 BioFarma

6.5.1 BioFarma Company Information

6.5.2 BioFarma Description and Business Overview

6.5.3 BioFarma TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 BioFarma TB Disease Vaccine Product Portfolio

6.5.5 BioFarma Recent Developments/Updates

6.6 GreenSignal Bio Pharma

6.6.1 GreenSignal Bio Pharma Company Information

6.6.2 GreenSignal Bio Pharma Description and Business Overview

6.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GreenSignal Bio Pharma TB Disease Vaccine Product Portfolio

6.6.5 GreenSignal Bio Pharma Recent Developments/Updates

6.7 China National Biotec

6.7.1 China National Biotec Company Information

6.7.2 China National Biotec Description and Business Overview

6.7.3 China National Biotec TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 China National Biotec TB Disease Vaccine Product Portfolio

6.7.5 China National Biotec Recent Developments/Updates

6.8 Biomed Lublin

6.8.1 Biomed Lublin Company Information

6.8.2 Biomed Lublin Description and Business Overview

6.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Biomed Lublin TB Disease Vaccine Product Portfolio

6.8.5 Biomed Lublin Recent Developments/Updates

6.9 Taj Pharmaceuticals

6.9.1 Taj Pharmaceuticals Company Information

6.9.2 Taj Pharmaceuticals Description and Business Overview

6.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Taj Pharmaceuticals TB Disease Vaccine Product Portfolio

6.9.5 Taj Pharmaceuticals Recent Developments/Updates

6.10 Ataulpho de Paiva

6.10.1 Ataulpho de Paiva Company Information

6.10.2 Ataulpho de Paiva Description and Business Overview

6.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Ataulpho de Paiva TB Disease Vaccine Product Portfolio

6.10.5 Ataulpho de Paiva Recent Developments/Updates

6.11 IVAC

6.11.1 IVAC Company Information

6.11.2 IVAC Description and Business Overview

6.11.3 IVAC TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 IVAC TB Disease Vaccine Product Portfolio

6.11.5 IVAC Recent Developments/Updates

6.12 Queen Saovabha Mem. Inst

6.12.1 Queen Saovabha Mem. Inst Company Information

6.12.2 Queen Saovabha Mem. Inst Description and Business Overview

6.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolio

6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates

6.13 Microgen

6.13.1 Microgen Company Information

6.13.2 Microgen Description and Business Overview

6.13.3 Microgen TB Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Microgen TB Disease Vaccine Product Portfolio

6.13.5 Microgen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 TB Disease Vaccine Industry Chain Analysis

7.2 TB Disease Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 TB Disease Vaccine Production Mode & Process Analysis

7.4 TB Disease Vaccine Sales and Marketing

7.4.1 TB Disease Vaccine Sales Channels

7.4.2 TB Disease Vaccine Distributors

7.5 TB Disease Vaccine Customer Analysis

8 TB Disease Vaccine Market Dynamics

8.1 TB Disease Vaccine Industry Trends

8.2 TB Disease Vaccine Market Drivers

8.3 TB Disease Vaccine Market Challenges

8.4 TB Disease Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global TB Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global TB Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global TB Disease Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global TB Disease Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global TB Disease Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global TB Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global TB Disease Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market TB Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of TB Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of TB Disease Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of TB Disease Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of TB Disease Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global TB Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global TB Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global TB Disease Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global TB Disease Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global TB Disease Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global TB Disease Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global TB Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global TB Disease Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global TB Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global TB Disease Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America TB Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America TB Disease Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America TB Disease Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America TB Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America TB Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe TB Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe TB Disease Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe TB Disease Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe TB Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe TB Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific TB Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific TB Disease Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific TB Disease Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific TB Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific TB Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America TB Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America TB Disease Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America TB Disease Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America TB Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America TB Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa TB Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa TB Disease Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa TB Disease Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa TB Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa TB Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global TB Disease Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global TB Disease Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global TB Disease Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global TB Disease Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global TB Disease Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global TB Disease Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global TB Disease Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global TB Disease Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global TB Disease Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global TB Disease Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global TB Disease Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global TB Disease Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global TB Disease Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global TB Disease Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global TB Disease Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global TB Disease Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global TB Disease Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global TB Disease Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global TB Disease Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global TB Disease Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck TB Disease Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. Japan BCG Lab Company Information

Table 76. Japan BCG Lab Description and Business Overview

Table 77. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Japan BCG Lab TB Disease Vaccine Product

Table 79. Japan BCG Lab Recent Developments/Updates

Table 80. Serum Institute of India Company Information

Table 81. Serum Institute of India Description and Business Overview

Table 82. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Serum Institute of India TB Disease Vaccine Product

Table 84. Serum Institute of India Recent Developments/Updates

Table 85. AJ Vaccines Company Information

Table 86. AJ Vaccines Description and Business Overview

Table 87. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. AJ Vaccines TB Disease Vaccine Product

Table 89. AJ Vaccines Recent Developments/Updates

Table 90. BioFarma Company Information

Table 91. BioFarma Description and Business Overview

Table 92. BioFarma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. BioFarma TB Disease Vaccine Product

Table 94. BioFarma Recent Developments/Updates

Table 95. GreenSignal Bio Pharma Company Information

Table 96. GreenSignal Bio Pharma Description and Business Overview

Table 97. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. GreenSignal Bio Pharma TB Disease Vaccine Product

Table 99. GreenSignal Bio Pharma Recent Developments/Updates

Table 100. China National Biotec Company Information

Table 101. China National Biotec Description and Business Overview

Table 102. China National Biotec TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. China National Biotec TB Disease Vaccine Product

Table 104. China National Biotec Recent Developments/Updates

Table 105. Biomed Lublin Company Information

Table 106. Biomed Lublin Description and Business Overview

Table 107. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Biomed Lublin TB Disease Vaccine Product

Table 109. Biomed Lublin Recent Developments/Updates

Table 110. Taj Pharmaceuticals Company Information

Table 111. Taj Pharmaceuticals Description and Business Overview

Table 112. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Taj Pharmaceuticals TB Disease Vaccine Product

Table 114. Taj Pharmaceuticals Recent Developments/Updates

Table 115. Ataulpho de Paiva Company Information

Table 116. Ataulpho de Paiva Description and Business Overview

Table 117. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Ataulpho de Paiva TB Disease Vaccine Product

Table 119. Ataulpho de Paiva Recent Developments/Updates

Table 120. IVAC Company Information

Table 121. IVAC Description and Business Overview

Table 122. IVAC TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. IVAC TB Disease Vaccine Product

Table 124. IVAC Recent Developments/Updates

Table 125. Queen Saovabha Mem. Inst Company Information

Table 126. Queen Saovabha Mem. Inst Description and Business Overview

Table 127. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Queen Saovabha Mem. Inst TB Disease Vaccine Product

Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates

Table 130. Microgen Company Information

Table 131. Microgen Description and Business Overview

Table 132. Microgen TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Microgen TB Disease Vaccine Product

Table 134. Microgen Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. TB Disease Vaccine Distributors List

Table 138. TB Disease Vaccine Customers List

Table 139. TB Disease Vaccine Market Trends

Table 140. TB Disease Vaccine Market Drivers

Table 141. TB Disease Vaccine Market Challenges

Table 142. TB Disease Vaccine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of TB Disease Vaccine

Figure 2. Global TB Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global TB Disease Vaccine Market Share by Type: 2024 & 2031

Figure 4. Prevention Vaccines Product Picture

Figure 5. Post-exposure Vaccines Product Picture

Figure 6. Others Product Picture

Figure 7. Global TB Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global TB Disease Vaccine Market Share by Application: 2024 & 2031

Figure 9. Self-Procurement

Figure 10. UNICEF

Figure 11. Others

Figure 12. Global TB Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global TB Disease Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global TB Disease Vaccine Sales (2020-2031) & (K Units)

Figure 15. Global TB Disease Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 16. TB Disease Vaccine Report Years Considered

Figure 17. TB Disease Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global TB Disease Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest TB Disease Vaccine Players: Market Share by Revenue in TB Disease Vaccine in 2024

Figure 20. TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global TB Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America TB Disease Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America TB Disease Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. U.S. TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe TB Disease Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe TB Disease Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific TB Disease Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific TB Disease Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America TB Disease Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Latin America TB Disease Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Mexico TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa TB Disease Vaccine Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa TB Disease Vaccine Revenue Market Share by Country (2020-2031)

Figure 52. Turkey TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E TB Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of TB Disease Vaccine by Type (2020-2031)

Figure 56. Global Revenue Market Share of TB Disease Vaccine by Type (2020-2031)

Figure 57. Global TB Disease Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of TB Disease Vaccine by Application (2020-2031)

Figure 59. Global Revenue Market Share of TB Disease Vaccine by Application (2020-2031)

Figure 60. Global TB Disease Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 61. TB Disease Vaccine Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global TB Disease Vaccine market? zhanKai

The top companies in the global TB Disease Vaccine market are Merck、Japan BCG Lab、Serum Institute of India.

Related Reports

Global TB Disease Vaccine Market Insights, Forecast to 2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global TB Disease Vaccine Market Research Report 2024
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
TB Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-01-07
Pages: 130
USD 3950.00
(Single User License)

Global TB Disease Vaccine Market Insights, Forecast to 2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)
Global TB Disease Vaccine Market Research Report 2024
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)
TB Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-01-07
Pages: 130
USD 3950.00 (Single User License)